Skip to main content
SpringerLink
Log in

Drug-induced Myopathies

  • Chapter
Atlas of Skeletal Muscle Pathology

Part of the book series: Current Histopathology ((CUHI,volume 9))

  • 228 Accesses

Abstract

Steroid myopathy is probably the commonest iatrogenic muscle disorder, but many unrelated drugs can cause myopathies. Adverse reactions are often idiosyncratic and unpredictable. Clinical and histological findings are varied, but rarely unique and can resemble other neuromuscular diseases. The drug-induced myopathies described here are but a few well-recognized examples that illustrate the range of pathological reactions. Many other drugs have been incriminated and more will be added to the list. In clinical practice a high index of suspicion and careful note of all medication is needed to identify a drug-related myopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mastaglia, F. L. (1982). Adverse effects of drugs on muscle. Drugs, 24, 304–321

    Article  PubMed  CAS  Google Scholar 

  2. Brown, J. A., Wollman, R. L. and Mullan, S. (1982). Myopathy induced by epsilon-aminocaproic acid. J. Neurosurg., 57, 130–134

    Article  PubMed  CAS  Google Scholar 

  3. Biswas, C. K., Reid Milligan, D. A., Agte, S. D. and Tilley, P.J. B. (1980). Acute renal failure and myopathy after treatment with aminocaproic acid. Br. Med. J., 281, 115–16

    Article  PubMed  CAS  Google Scholar 

  4. Abourizk, N., Khalil, B.A., Bahath, N. and Afifi, A. K. (1979). Clofibrate-induced muscular syndrome. J. Neurol. Sci., 42, 1 –9

    Article  PubMed  CAS  Google Scholar 

  5. Smals, A.G.H., Beex, L. V.A. M. and Kloppenborg, P. W. C. (1977). Clofibrate-induced muscle damage with myoglobinuria and cardiomyopathy. N. Engl. J. Med., 296, 942

    PubMed  CAS  Google Scholar 

  6. Britt, C.W., Light, R.R., Peters, B.H. and Schochet, S. S. (1980). Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Arch. Neurol., 37, 187–8

    PubMed  Google Scholar 

  7. Khaleeli, A. A., Edwards, R. H. T., Gohil, K., McPhail, G., Rennie, M.J., Round, J. and Ross, E.J. (1983). Corticosteroid myopathy: a clinical and pathological study. Clin. Endocrinol., 18, 155–66

    Article  CAS  Google Scholar 

  8. Askari, A., Vignos, P.J. and Moskowitz, R.W. (1976). Steroid myopathy in connective tissue disease. Am. J. Med., 61, 485–92

    Article  Google Scholar 

  9. Brauntein, P. W. and DeGirolami, U. (1981). Experimental corticosteroid myopathy. Acta Neuropathol., 55, 167–72

    Article  Google Scholar 

  10. Van Marie, W. and Woods, K. L. (1980). Acute hydrocortisone myopathy. Br. Med. J., 281, 271–2

    Google Scholar 

  11. Harriman, D.G.F. (1971). The fine structure of intramuscular lipids in human skeletal muscle. In Basic Research in Myology. International congress series No. 294. Excerpta Medica, Amsterdam.

    Google Scholar 

  12. Schwartz, H. A., Slavin, G., Ward, P. and Ansell, B. A. (1980). Muscle biopsy in polymyositis and dermatomyositis; a clinico- pathoiogical study. Ann. Rheum. Dis., 39, 500–7

    Article  Google Scholar 

  13. Perkoff, G.T., Dioso, M.M., Bleisch, V. and Klinkerfuss, G. (1967). Spectrum of myopathy associated with alcoholism. I. Clinical and laboratory features. Ann. Intern. Med., 67, 481–92

    Google Scholar 

  14. Klinkerfuss, G., Bleisch, V., Dioso, M.M. and Perkoff, G.T. (1967). A spectrum of myopathy associated with alcoholism.II. Light and electron microscopic observations. Ann. Intern. Med., 67, 493–510

    PubMed  CAS  Google Scholar 

  15. Rubin, E. (1979). Alcoholic myopathy in heart and skeletal muscle. N. Engl. J. Med., 301, 28–33

    Article  PubMed  CAS  Google Scholar 

  16. Puszkin, S. and Rubin, E. (1 975). Adenosine diphosphate effect on contractility of human muscle actomyosin: inhibition by ethanol and acetaldehyde. Science, 188, 1319–20

    Google Scholar 

  17. Hanid, A., Slavin, G., Mair, W., Sowter, C., Ward, P., Webb, J. and Levi, A. J. (1981). Fibres type changes in striated muscles of alcoholics. J. Clin. Pathol., 34, 991–5

    Article  PubMed  CAS  Google Scholar 

  18. Perkoff, G.T. (1971). Alcoholic myopathy. Ann. Rev. Med., 22, 125–31

    Article  PubMed  CAS  Google Scholar 

  19. Slavin, G., Martin, F., Levi, J. and Peters, T. (1983). Chronic alcohol excess is associated with selective but reversible injury to type 2B muscle fibres. J. Clin. Pathol., 36, 772–7

    Article  PubMed  CAS  Google Scholar 

  20. Sunnasy, D., Cairns, S.R., Martin, F., Slavin, G., Peters, T.J. (1983). Chronic alcoholic skeletal muscle myopathy: a clinical, histological and biochemical assessment of muscle lipid. J. Clin. Pathol., 36, 778–84

    CAS  Google Scholar 

  21. Del Villar Negro, A., Merino Angulo, J., Rivera Pomar, J. M. and Aguirre Errasti, C. (1982). Tubular aggregates in skeletal muscle of chronic alcoholic patients. Acta Neuropathol., 56, 250–4

    Article  Google Scholar 

  22. Trout, J.J., Stauber, W.T. and Schottelius, B.A. (1981). Increased autophagy in chloroquine-treated tonic and phasic muscles; an alternative view. Tissue and Cell, 13, 393–401

    Article  PubMed  CAS  Google Scholar 

  23. Schmalbruch, H. (1980). The early changes in experimental myopathy induced by chloroquine and chlorphentermine. J. Neuropathol. Exp. Neurol., 39, 65–81

    Article  PubMed  CAS  Google Scholar 

  24. Mastaglia, F. L., Papadimitriou, J.M., Dawkins, R.L. and Beveridge, B. (1977). Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. J. Neurol. Sci., 34, 3

    Article  Google Scholar 

  25. Neville, H.E., Maunder-Sewry, C.A., McDougall, J., Sewell, J. R. and Dubowitz, V. (1979). Chloroquine-induced cytosomes with curvilinear profiles in muscle. Muscle and Nerve, 2, 376–81

    Article  PubMed  CAS  Google Scholar 

  26. Garlepp, M.J., Dawkins, R.L. and Christiansen, F. T. (1983). HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br. Med. J., 286, 338–40

    Article  CAS  Google Scholar 

  27. Donker, A. J., Venuto, R. C., Vladutiu, A. O., Brentjens, J. R. and Andres, G. A. (1984). Effects of prolonged administration of D- penicillamine or Captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop auto-antibodies, circulating immune complexes and disseminated intravascular coagulation. Clin. Immunol. Immunopathol., 30, 142–55

    Article  PubMed  CAS  Google Scholar 

  28. Burres, S.A., Kanter, M.E., Richman, D. P. and Arnason, B.G. W. (1981). Studies on the pathophysiology of chronic D- penicillamine-induced myasthenia. Ann. NY Acad, Sci., 377, 640–51

    Article  CAS  Google Scholar 

  29. Bever, C.T. et al. (1982). Penicillamine induced myasthenia gravis: effects of penicillamine on acetylcholine receptor. Neurology, 32, 1077–82

    PubMed  CAS  Google Scholar 

  30. Doyle, D.R., McCurely, T. L. and Sergent, J.S. (1983). Fatal polymyositis in D-pencillamine treated rheumatoid arthritis. Ann Intern. Med. 98, 327–30

    PubMed  CAS  Google Scholar 

  31. Gronert, G. A. (1980). Malignant hyperthermia. Anesthesiology, 53, 395–423

    Article  PubMed  CAS  Google Scholar 

  32. Thompson, D.E.A. and Tallack, J.A. (1973). Co-existent muscle disease and malignant hyperpyrexia. In Gordon, R. A. et al, (eds.) International Symposium on Malignant Hyperthermia. (Springfield, III: Charles C. Thomas ), pp. 309–18

    Google Scholar 

  33. Leiding, K.G. and Graham, M. D. (1981). Malignant hyperthermia. Arch. Otolaryngol., 107, 758–60

    Google Scholar 

  34. Frank, J. P., Harati, Y., Butler, I. J., Nelson, T. E. and Scott, C. I. (1980). Central core disease and malignant hyperthermia syndrome. Ann. Neurol., 7, 11–17

    Article  PubMed  CAS  Google Scholar 

  35. Brownell, A.K.W., Paasuke, R.T., Elash, R.T., Fowlow, S.B., Seagram, C.G.F., Diewold, R.J. and Friesen, C. (1983). Malignant hyperthermia in Duchenne muscular dystrophy. Anesthesiology, 58, 180–2

    Article  PubMed  CAS  Google Scholar 

  36. Rosenberg, H. and Heiman-Patterson, T. (1983). Duchenne’s muscular dystrophy and malignant hyperthermia: another warn ing. Anesthesiology, 59, 362

    Article  PubMed  CAS  Google Scholar 

  37. Denborough, M.A., Galloway, G.J. and Hopkinson, K.C. (1982). Malignant hyperpyrexia and sudden infant death. Lancet, 2, 1068–9

    Article  PubMed  CAS  Google Scholar 

  38. Kalow, W., Britt, B. A. and Richter, A. (1977). The caffeine test of isolated human muscle in relation to malignant hyperthermia. Can. Anaesthesiol. Soc. J., 24, 678–94

    Article  CAS  Google Scholar 

  39. Kalow, W., Butt, B. A. and Peters, P. (1978). Rapid simplified techniques for measuring caffeine contracture for patients with malignant hyperthermia. In Aldrete, J. A. and Britt, B.A. (eds.) Second International Symposium on Malignant Hyperthermia. ( New York: Grune and; Stratton ), pp. 339–350

    Google Scholar 

  40. Gronert, G. A. (1983). Controversies in malignant hyperthermia. Anesthesiology, 59, 273–4

    Article  PubMed  CAS  Google Scholar 

  41. Mambo, N.C., Silver, M.D., McLaughlin, P. R., Huckell, V. F., McEwan, P.M., Britt, B.A. and Morch, J.E. (1980). Malignant hyperthermia susceptibility. Human Pathol., 11, 381–8

    Article  CAS  Google Scholar 

  42. Harriman, D.G.F. (1982). The pathology of malignant hyperpyrexia. In Walton, J. and Mastalgia, F. L. (eds.) Skeletal Muscle Pathology. ( Edinburgh: Churchill Livingstone ), pp. 575–91

    Google Scholar 

  43. Harriman, D.G.F., Ellis, F.R., Franks, A.J. et al. (1978). Malignant hyperthermia: an investigation of 75 families. In Aldrete, J.A. and Britt, B.A. (eds.) Second International Symposium on Malignant Hyperthermia. ( New York: Grune & Stratton ), pp. 67–87

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Morbid Anatomy and Histopathology, Addensbrooke’s Hospital, Cambridge, UK

    Janice R. Anderson

Authors
  1. Janice R. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Janice R. Anderson

About this chapter

Cite this chapter

Anderson, J.R. (1985). Drug-induced Myopathies. In: Atlas of Skeletal Muscle Pathology. Current Histopathology, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4866-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4866-2_16

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8653-0

  • Online ISBN: 978-94-009-4866-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation